EC Number   |
|---|
    6.1.1.20 | - |
| 6.1.1.20 | at 0.6-nm resolution |
| 6.1.1.20 | crystal structure at 2.9 A resolution |
| 6.1.1.20 | crystal structure of complexes of enzyme with L-Tyr, p-chlorophenylalanine, and L-tyrosyl-adenylate |
| 6.1.1.20 | crystal structure of enzyme complexed with cognate tRNAPhe |
| 6.1.1.20 | enzyme complexed with phenylalanine or the phenylalanyl-adenylate analogue phenylalaninyl-adenylate, X-ray diffraction structure determination at 2.7 and 2.5 A resolution, respectively, and analysis |
| 6.1.1.20 | in complex with 3,4-dihydroxy-L-phenylalanine |
| 6.1.1.20 | native enzyme complexed with phenylalanyl-adenylate in presence of manganese, X-ray diffraction structure determination at 2.6 A resolution and analysis |
| 6.1.1.20 | native enzyme crystals are of poor quality diffracting only to 3-5 A resolution, engineered mutant enzymes diffracts to 2.0 A resolution, X-ray diffraction structure determination and analysis, overview |
| 6.1.1.20 | PheRS in complex with with cognate tRNAPhe and nonhydrolyzable phenylalanyladenylate analogue PheOH-AMP, hanging-drop vapor-diffusion method, 4°C, 3-5 mg/ml protein ina ratio of 1:2,5 with tRNAPhe in 20 mM imidazole-HCl, pH 7.8, 1 mM MgCl2, 5 mM 2-mercaptoethanol, 1 mM NaN3, 10% saturated ammonium sulfate, and 1 mM PheOH-AMP, slow equilibration against a reservoir solution containing the crystallization buffer and 27% saturated ammonium sulfate, cryoprotection by 30% v/v glycerol, X-ray diffraction structure determination and anaylsis at 3.1 A resolution, modeling |
